Skip to main content
. 2022 Jul 28;12(8):704. doi: 10.3390/metabo12080704

Table 1.

Clinicopathological characteristics of the study group.

Feature Value
Tumor location Cecum: 2 (5.13%)
Ascending colon: 6 (15.38%)
Transverse colon: 3 (7.69%)
Descending colon: 1 (2.56%)
Sigmoid colon and rectosigmoid junction: 6 (15.36%)
Rectum: 13 (33.33%)
left colon: 13 (33.33%)
Left colon and rectum: 26 (66.67%)
Colon: 26 (66.67%) Rectum: 13 (33.33%)
Gender Male:18 (46.2%); Female: 21(53.8%)
Grading G1:0 (0%); G2: 22 (56.4%); G3: 17(43.6%)
T I: 1 (2.56%); II: 16 (41.03%);
III: 20 (51.28%); IV: 2 (5.13%)
N N0: 24 (61.54%); N1: 4 (10.26%); N2: 11 (28.21%)
M M0: 36 (92.31%); M1: 3 (7.69%)
TNM staging I: 14 (35.9%); II: 9 (23.08%);
III: 13 (33.33%); IV: 3 (7.69%)
Astler-Coller staging A1: 1 (2.56%); B1: 13 (33.33%); B2: 8 (20.51%);
C1: 3 (7.69%); C2: 11 (28.21%); D: 3 (7.69%)